Cognitive Enhancement in Schizophrenia. Pharmacological and Cognitive Remediation Approaches

Philip D Harvey, Christopher R. Bowie

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

This article discusses the measurement of cognition in schizophrenia, its role as a determinant of disability, and treatment efforts to date, including pharmacological and behavioral interventions as well as effective treatments that lead to improved outcomes. The measurement of functioning when patients with schizophrenia receive treatment in the office is addressed. The review focuses on new developments in the creation and adoption of a consensus method for the assessment of cognitive functioning in treatment studies, on the increased appreciation for assessment of functional skills in the prediction of everyday outcomes, and on developments in the basic neuroscience of cognition.

Original languageEnglish
Pages (from-to)683-698
Number of pages16
JournalPsychiatric Clinics of North America
Volume35
Issue number3
DOIs
StatePublished - Sep 1 2012

Fingerprint

Schizophrenia
Pharmacology
Cognition
Therapeutics
Neurosciences
Consensus
Cognitive Remediation

Keywords

  • Cognitive enhancement
  • Pharmacological treatment
  • Schizophrenia

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Cognitive Enhancement in Schizophrenia. Pharmacological and Cognitive Remediation Approaches. / Harvey, Philip D; Bowie, Christopher R.

In: Psychiatric Clinics of North America, Vol. 35, No. 3, 01.09.2012, p. 683-698.

Research output: Contribution to journalArticle

@article{6e1b50c0728847feafe9d4568f591d86,
title = "Cognitive Enhancement in Schizophrenia. Pharmacological and Cognitive Remediation Approaches",
abstract = "This article discusses the measurement of cognition in schizophrenia, its role as a determinant of disability, and treatment efforts to date, including pharmacological and behavioral interventions as well as effective treatments that lead to improved outcomes. The measurement of functioning when patients with schizophrenia receive treatment in the office is addressed. The review focuses on new developments in the creation and adoption of a consensus method for the assessment of cognitive functioning in treatment studies, on the increased appreciation for assessment of functional skills in the prediction of everyday outcomes, and on developments in the basic neuroscience of cognition.",
keywords = "Cognitive enhancement, Pharmacological treatment, Schizophrenia",
author = "Harvey, {Philip D} and Bowie, {Christopher R.}",
year = "2012",
month = "9",
day = "1",
doi = "10.1016/j.psc.2012.06.008",
language = "English",
volume = "35",
pages = "683--698",
journal = "Psychiatric Clinics of North America",
issn = "0193-953X",
publisher = "W.B. Saunders Ltd",
number = "3",

}

TY - JOUR

T1 - Cognitive Enhancement in Schizophrenia. Pharmacological and Cognitive Remediation Approaches

AU - Harvey, Philip D

AU - Bowie, Christopher R.

PY - 2012/9/1

Y1 - 2012/9/1

N2 - This article discusses the measurement of cognition in schizophrenia, its role as a determinant of disability, and treatment efforts to date, including pharmacological and behavioral interventions as well as effective treatments that lead to improved outcomes. The measurement of functioning when patients with schizophrenia receive treatment in the office is addressed. The review focuses on new developments in the creation and adoption of a consensus method for the assessment of cognitive functioning in treatment studies, on the increased appreciation for assessment of functional skills in the prediction of everyday outcomes, and on developments in the basic neuroscience of cognition.

AB - This article discusses the measurement of cognition in schizophrenia, its role as a determinant of disability, and treatment efforts to date, including pharmacological and behavioral interventions as well as effective treatments that lead to improved outcomes. The measurement of functioning when patients with schizophrenia receive treatment in the office is addressed. The review focuses on new developments in the creation and adoption of a consensus method for the assessment of cognitive functioning in treatment studies, on the increased appreciation for assessment of functional skills in the prediction of everyday outcomes, and on developments in the basic neuroscience of cognition.

KW - Cognitive enhancement

KW - Pharmacological treatment

KW - Schizophrenia

UR - http://www.scopus.com/inward/record.url?scp=84865427240&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865427240&partnerID=8YFLogxK

U2 - 10.1016/j.psc.2012.06.008

DO - 10.1016/j.psc.2012.06.008

M3 - Article

VL - 35

SP - 683

EP - 698

JO - Psychiatric Clinics of North America

JF - Psychiatric Clinics of North America

SN - 0193-953X

IS - 3

ER -